{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Generalised pustular psoriasis",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_apremilast",
          "name": "Apremilast"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_acitretin",
          "name": "Acitretin"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_cyclosporine",
          "name": "Cyclosporine"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_etanercept",
          "name": "Etanercept"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_vedolizumab",
          "name": "Vedolizumab"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_secukinumab",
          "name": "Secukinumab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_brodalumab",
          "name": "Brodalumab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_tazarotene",
          "name": "Tazarotene"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot_infliximab",
          "type": "Target",
          "label": "Infliximab Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_infliximab",
          "type": "Pathway",
          "label": "Infliximab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_infliximab",
          "type": "Phenotype",
          "label": "Adverse Effects of Infliximab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_adalimumab",
          "type": "Target",
          "label": "Adalimumab Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_adalimumab",
          "type": "Pathway",
          "label": "Adalimumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_adalimumab",
          "type": "Phenotype",
          "label": "Adverse Effects of Adalimumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_apremilast",
          "type": "Target",
          "label": "Apremilast Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_apremilast",
          "type": "Pathway",
          "label": "Apremilast Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_apremilast",
          "type": "Phenotype",
          "label": "Adverse Effects of Apremilast",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_acitretin",
          "type": "Target",
          "label": "Acitretin Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_acitretin",
          "type": "Pathway",
          "label": "Acitretin Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_acitretin",
          "type": "Phenotype",
          "label": "Adverse Effects of Acitretin",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_methotrexate",
          "type": "Target",
          "label": "Methotrexate Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_methotrexate",
          "type": "Pathway",
          "label": "Methotrexate Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_methotrexate",
          "type": "Phenotype",
          "label": "Adverse Effects of Methotrexate",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_cyclosporine",
          "type": "Target",
          "label": "Cyclosporine Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_cyclosporine",
          "type": "Pathway",
          "label": "Cyclosporine Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_cyclosporine",
          "type": "Phenotype",
          "label": "Adverse Effects of Cyclosporine",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_etanercept",
          "type": "Target",
          "label": "Etanercept Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_etanercept",
          "type": "Pathway",
          "label": "Etanercept Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_etanercept",
          "type": "Phenotype",
          "label": "Adverse Effects of Etanercept",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_vedolizumab",
          "type": "Target",
          "label": "Vedolizumab Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_vedolizumab",
          "type": "Pathway",
          "label": "Vedolizumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_vedolizumab",
          "type": "Phenotype",
          "label": "Adverse Effects of Vedolizumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_ustekinumab",
          "type": "Target",
          "label": "Ustekinumab Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_ustekinumab",
          "type": "Pathway",
          "label": "Ustekinumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_ustekinumab",
          "type": "Phenotype",
          "label": "Adverse Effects of Ustekinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_secukinumab",
          "type": "Target",
          "label": "Secukinumab Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_secukinumab",
          "type": "Pathway",
          "label": "Secukinumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_secukinumab",
          "type": "Phenotype",
          "label": "Adverse Effects of Secukinumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_brodalumab",
          "type": "Target",
          "label": "Brodalumab Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_brodalumab",
          "type": "Pathway",
          "label": "Brodalumab Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_brodalumab",
          "type": "Phenotype",
          "label": "Adverse Effects of Brodalumab",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot_tazarotene",
          "type": "Target",
          "label": "Tazarotene Off-Target",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_tazarotene",
          "type": "Pathway",
          "label": "Tazarotene Risk Pathway",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_tazarotene",
          "type": "Phenotype",
          "label": "Adverse Effects of Tazarotene",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_infliximab",
          "target": "n_ot_infliximab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_infliximab",
          "target": "n_rp_infliximab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_infliximab",
          "target": "n_adv_infliximab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_infliximab",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_ot_adalimumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_adalimumab",
          "target": "n_rp_adalimumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_adalimumab",
          "target": "n_adv_adalimumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_adalimumab",
          "target": "H2",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_apremilast",
          "target": "n_ot_apremilast",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_apremilast",
          "target": "n_rp_apremilast",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_apremilast",
          "target": "n_adv_apremilast",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_apremilast",
          "target": "H3",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_acitretin",
          "target": "n_ot_acitretin",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_acitretin",
          "target": "n_rp_acitretin",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_acitretin",
          "target": "n_adv_acitretin",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_acitretin",
          "target": "H4",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_methotrexate",
          "target": "n_ot_methotrexate",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_methotrexate",
          "target": "n_rp_methotrexate",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_methotrexate",
          "target": "n_adv_methotrexate",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_methotrexate",
          "target": "H5",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_cyclosporine",
          "target": "n_ot_cyclosporine",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_cyclosporine",
          "target": "n_rp_cyclosporine",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_cyclosporine",
          "target": "n_adv_cyclosporine",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_cyclosporine",
          "target": "H6",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_etanercept",
          "target": "n_ot_etanercept",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_etanercept",
          "target": "n_rp_etanercept",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_etanercept",
          "target": "n_adv_etanercept",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_etanercept",
          "target": "H7",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_vedolizumab",
          "target": "n_ot_vedolizumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_vedolizumab",
          "target": "n_rp_vedolizumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_vedolizumab",
          "target": "n_adv_vedolizumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_vedolizumab",
          "target": "H8",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_ustekinumab",
          "target": "n_ot_ustekinumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_ustekinumab",
          "target": "n_rp_ustekinumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_ustekinumab",
          "target": "n_adv_ustekinumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_ustekinumab",
          "target": "H9",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_secukinumab",
          "target": "n_ot_secukinumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_secukinumab",
          "target": "n_rp_secukinumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_secukinumab",
          "target": "n_adv_secukinumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_secukinumab",
          "target": "H10",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_brodalumab",
          "target": "n_ot_brodalumab",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_brodalumab",
          "target": "n_rp_brodalumab",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_brodalumab",
          "target": "n_adv_brodalumab",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_brodalumab",
          "target": "H11",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        },
        {
          "source": "drug_tazarotene",
          "target": "n_ot_tazarotene",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的不良作用途径"
        },
        {
          "source": "n_ot_tazarotene",
          "target": "n_rp_tazarotene",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "相关风险通路"
        },
        {
          "source": "n_rp_tazarotene",
          "target": "n_adv_tazarotene",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良表型"
        },
        {
          "source": "n_adv_tazarotene",
          "target": "H12",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能抵消益处"
        }
      ],
      "merge": [],
      "set_weights": [],
      "conflict_hotspots": []
    },
    "counterclaims": [],
    "assumptions_challenged": [
      "各药物的不同靶点对疾病的影响是否一致",
      "不同药物引发的潜在不良反应的严重性及方向性是否具有相似性"
    ],
    "falsification_tests": [
      "是否存在针对上述药物安全性的系统评估文献？",
      "是否存在临床试验显示不同药物在该病的相对疗效比较？"
    ],
    "next_focus_for_pi": [
      "比较不同药物引发的不良事件总结及其临床表现",
      "针对各药物的上述风险通路进行深入研究"
    ]
  }
}